News

Hexarelin, a synthetic hexapeptide, has garnered attention in various research domains due to its intriguing biochemical ...
Tesamorelin, a synthetic growth hormone-releasing hormone (GHRH) analog, has garnered significant attention in scientific ...
Peptide hormones are key messengers in the signaling network between the nervous system, endocrine glands, energy stores and the gastrointestinal tract that regulates feeding and metabolism. Studies ...
A new study from Imperial has shown that the physical structure of food influences the hormones released as part of digestion ...
Previous angiographic studies, admittedly using nonspecific assays for plasma insulin, have also consistently failed to demonstrate a statistically significant association between plasma insulin level ...
I had the conversation I'd been preparing for over four years. Jay Campbell, author of The Testosterone Optimization Bible ...
One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...
GLP-1 drugs are revolutionizing the treatment of obesity and diabetes. Here's what to know about investing in GLP-1 stocks.
GLP-1 inhibits glucagon release, which is a hormone that raises blood sugar levels. GLP-1 prolongs gastric emptying and leads ...
A new study links high insulin levels to irregular periods in women, suggesting blood sugar issues—not just hormones—could be behind abnormal uterine bleeding.
Insulin-degrading enzyme (IDE) is an atypical zinc-metallopeptidase that degrades insulin and the amyloid ß-protein and is strongly implicated in the pathogenesis of diabetes and Alzheimer’s disease.